Rhode Island HB 7116: AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACEUTICAL COST TRANSPARENCY (Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.)

Status: 02/01/2022 Committee recommended measure be held for further study (as of 2022-02-01)

State: Rhode Island · Session: 2022 · Bill: HB 7116

Sponsors: J Lombardi, Morales

View Rhode Island HB 7116 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.